维普中文期刊产品整合服务
78篇 您的检索式:作者名="Tilton RG"
    题名 作者 年代 出处 被引量
1Glycosylation induced increases in blood flow and 125I - albamn permeation : role of nitric oxide and superoxide (abstract) 显示文摘Tilton RG Chang K Allison W 1993FASEB1993,7,:1
2Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes显示文摘 Tilton RG Elger M 2001J Am Soc Nephro2001,112,:1
3Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist显示文摘Tilton RG Munsch CL Sherwood SJ Chen YF Wu C 2000Pulm Pharmacol Ther2000,13,:1
4Myofibroblast tranedifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia显示文摘De Vriese AS Tilton RG Mortier S 2006Nephrol Dial Transplant2006,21,9:1
5Capillary pericytes: perspectives and future trends显示文摘Tilton RG 1991Electron Microsc Tech1991,19,3:1
6A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes,the zucker diabetic fatty rat显示文摘Schrijvers BF Flyvbjerg A Tilton RG 2006Nephrol Dial Transplant2006,21,2:1
7Aneutralizing glomerular hypertrophyina model of zucker diabetic fatty rat显示文摘Schrijvers BF Flyvhjerg VEGF antibody prevents obese type2 diabetes the Dial transplant 2006 21 A Tilton RG 2006Nephrol2006,,2:1
8Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes显示文摘 Tilton RG Elger M 2001J Am Soc Nephrol2001,12,5:1
9Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production显示文摘Tilton RG Chang K Gorbett JA 1994Invest Ophthalmol Vis Sxi1994,35,7:1
10Antibodies against VEGF improve early renal dysfunction in experimental diabetes显示文摘Vriese AS Tilton RG Elger M 2001J Am Soc Nephrol2001,12,5:1
11Pathophysiological role of vascular endothelial growth factor in the remnant kidney 显示文摘Schrijvers BF Flyvbjerg A Tilton RG 2005Nephron Exp Nephrol2005,10,1:1
12Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes显示文摘de-Vriese AS Tilton RG Elger M 0,,:1
13Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ETA receptor antagonist 显示文摘Tilton RG Munsch CL Sherwood SJ 2000Pulm Pharmacol Ther2000,13,2:1
14Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes显示文摘Vriese AS Tilton RG Elger M 2001J Am Soc Nephrol2001,12,:1
15Antibodies agains tvascular endothelial growth factor improve early reaal dysfunction in experimental diabetes 显示文摘DeVriese AS Tilton RG Elger M etal 2001J Am Socnephrol2001,,12:1
16Glycosylation induced increases in blood flow and 125I-albamn permeation:role of nitric oxide and superoxide (abstract)显示文摘TILTON RG CHANG K ALLISON W 1993FASEB1993,7,:1
17Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes显示文摘Vriese AS Tilton RG Elger M 2001J Am Soc Nephrol2001,12,:1
18Antibodies against vascular endothelial growth factor improve early renal dysfunc- tion in experimental diabetes显示文摘De Vriese AS Tilton RG Elger M 2001J Am Soc Nephrol2001,12,5:1
19Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes显示文摘Vriese AS Tilton RG Elger M 2001J Am Soc Nephrol2001,12,5:1
20Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane显示文摘De Vriese AS Tilton RG Stephan CC 2001J Am Soc Nephrol2001,12,8:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费